tiprankstipranks
InnoCan Pharma’s Drug Shows Promise in Animal Trials
Company Announcements

InnoCan Pharma’s Drug Shows Promise in Animal Trials

InnoCan Pharma (TSE:INNO) has released an update.

Stay Ahead of the Market:

InnoCan Pharma has reported favorable results from a preliminary safety evaluation of its LPT-CBD drug on minipigs, with no adverse effects observed, supporting its potential in sustained-release therapy. This successful animal trial marks a significant step towards the drug’s further development and possible approval. The study supports previous positive evaluations in other animals and is part of InnoCan’s ongoing efforts to revolutionize patient care with their innovative drug delivery technologies.

For further insights into TSE:INNO stock, check out TipRanks’ Stock Analysis page.

Related Articles
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App